Biotech News

Notice of Proposed Derivative Settlement: Twist Bioscience Corporation

Twist Bioscience Corporation (TWST)Twist Bioscience CorporationCompany update

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Nov. 3, 2026-- Twist Bioscience Corporation (NASDAQ: TWST): UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE IN RE TWIST BIOSCIENCE CORPORATION DERIVATIVE LITIGATION Lead Case No. 1:23-cv-01048-MN SUMMARY NOTICE OF PROPOSED SETTLEMENT OF DERIVATIVE

Related news

Twist Bioscience Corporation

Synthetic Biology Platform Twist Bioscience manufactures customizable synthetic DNA and related biological products at scale. Its platform is designed to improve the speed, throughput and precision of research and development workflows. Oligos and Genes Core products include oligonucleotides, genes and complex DNA constructs used by...

Recent company news

Stock data

Close
111.62 USD
Market cap
4.37B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States